Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma

The prognosis for patients with multiple myeloma has improved substantially over the past decade with the development of new, more effective chemotherapeutic agents and regimens, and improved management of toxicities. Treatment of relapsed or refractory multiple myeloma represents a vital aspect of...

Full description

Bibliographic Details
Main Author: S. V. Semochkin
Format: Article
Language:Russian
Published: ABV-press 2020-07-01
Series:Onkogematologiâ
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/416